Article Details
Retrieved on: 2021-05-03 04:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Exclusive License acquisition for the mRNA technology platform. On April 29, 2021, Brooklyn ImmunoTherapeutics said that it has acquired an exclusive ...
Article found on: marketglobalist.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here